Screener / SEC EDGAR /CIK 0001773751 /10-K filed Feb 23, 2026, compared with Feb 24, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Offices & Clinics of Doctors of Medicine

Hims & Hers Health, Inc. HIMS

Compare with peers Embed
FY2025 at a glance

Sales up 59.0%, free cash flow down to $57.4M

XBRL, from each 10-K
RevenueStatements
$2.3B from $1.5B in FY2024
FY2019FY2025
Net incomeStatements
$128.4M from $126.0M in FY2024
FY2019FY2025
Free cash flowStatements
$57.4M from $198.3M in FY2024
FY2019FY2025
EPS (diluted)Statements
$0.51 from $0.53 in FY2024
FY2019FY2025
Operating marginStatements
4.5% from 4.2% in FY2024
FY2019FY2025

The latest figures

Price and key numbers

From EDGAR
All key numbers (38)
EPS (ttm)
-0.83
Sales (ttm)
2.9B
Net income (ttm)
-190.8M
Sales growth
+59.0%
EPS growth
-3.8%
Sales Q/Q
+48.6%
Free cash flow
8.2M
Gross margin
63.8%
Oper. margin
-8.1%
Net margin
-6.7%
FCF margin
0.3%
R&D / sales
-
Dividend
-
Debt/Eq
-
Curr. ratio
0.92
Cash
605.6M
Op. cash flow (ttm)
180.1M
EBITDA
160.1M
EBITDA margin
6.8%
Quick ratio
0.86
ROIC
30.8%
FCF after stock pay
-77.8M
Goodwill / assets
12.9%
Oper. margin low 5y
-42.3%
Tax rate
-3.6%
Stock pay / sales
5.8%
Shares out.
233.8M
Shares Y/Y
+9.0%
Book / share
1.52
Cash / share
2.59
Sales / share
12.27
Asset turnover
0.81
Inventory turns
7.67
Days sales out.
5
Sales 3Y CAGR
+64.5%
Sales 5Y CAGR
+73.6%

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Revenue and net income, FY2019 to FY2025

Each fiscal year from its own 10-K · XBRL

Revenue 2.3B +74.7% a year Net income 128.4M
FY2019 revenue 82.6M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001773751-22-000039 FY2019 net income -72.1M · NetIncomeLoss, 0001773751-22-000039 82.6M FY2019 FY2020 revenue 148.8M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001773751-23-000029 FY2020 net income -18.1M · NetIncomeLoss, 0001773751-23-000029 148.8M FY2020 FY2021 revenue 271.9M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001773751-24-000025 FY2021 net income -107.7M · NetIncomeLoss, 0001773751-24-000025 271.9M FY2021 FY2022 revenue 526.9M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001773751-25-000062 FY2022 net income -65.7M · NetIncomeLoss, 0001773751-25-000062 526.9M FY2022 FY2023 revenue 872.0M · RevenueFromContractWithCustomerExcludingAssessedTax, 0001773751-26-000022 FY2023 net income -23.5M · NetIncomeLoss, 0001773751-26-000022 872.0M FY2023 FY2024 revenue 1.5B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001773751-26-000022 FY2024 net income 126.0M · NetIncomeLoss, 0001773751-26-000022 1.5B FY2024 FY2025 revenue 2.3B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001773751-26-000022 FY2025 net income 128.4M · NetIncomeLoss, 0001773751-26-000022 2.3B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. "A year" is the steady yearly growth from FY2019 to FY2025 (6 years).

Growth per share, FY2019 to FY2025

Earnings, book value and free cash flow for each diluted share · 10-K XBRL, every year linked to its filing

Average yearly growth
Book value per share +4.0% a year FY2021 $1.79 to FY2025 $2.09, 4 years
Fiscal year toEPS (diluted)Book value / shareFree cash flow / share
Dec 31, 2025 $0.51$2.09$0.22
Dec 31, 2024 $0.53$2.01$0.84
Dec 31, 2023 -$0.11$1.64$0.22
Dec 31, 2022 -$0.32$1.52-$0.16
Dec 31, 2021 -$0.58$1.79-
Dec 31, 2020 -$0.51-$4.15-
Dec 31, 2019 -$2.07-$4.02-

Per share means per diluted weighted-average share of the same fiscal year (the count under diluted EPS, put on today's share count after a split). Book value is shareholders' equity at the year end, including any preferred stock; free cash flow is operating cash flow less capital spending. Each tile's rate is the steady yearly growth from the first to the last year it names: the window starts at the oldest year, up to ten years back, with a value above zero.

What the balance sheet holds, per share

Net current asset value and tangible book value, FY2025 · 10-K XBRL, no share price used

Net current asset value, FY2025, in dollars
  • + Current assets $767.6M
  • − All liabilities $1.6B
  • = Net current asset value -$846.1M
Per share, year by year
Tangible book value, FY2025, in dollars
  • + Shareholders' equity $540.9M
  • − Goodwill $278.3M
  • − Other intangible assets $196.1M
  • = Tangible book value $66.5M
Per share, year by year

Net current asset value is current assets minus all liabilities (the long-term ones too), so it is what would be left from the short-term assets after everything owed is paid; it is blank for a bank, which reports no current assets. Tangible book value is shareholders' equity minus goodwill and other intangible assets; equity includes any preferred stock. Both are divided by the diluted weighted-average share count of the same fiscal year. Red bars are amounts taken off, or a negative result.

HIMS against Health care peers

Among the 162 companies, the better end on the right. The band holds the middle half; the line is the median.

Ten years, side by side
Sales growth
+4.8%+20.2%
+59.0%14th of 155 · median +10.5%
Net margin
-4.1%15.3%
-6.7%122nd of 154 · median 6.8%
Return on equity
-5.2%18.5%
-53.7%135th of 144 · median 9.2%
Free cash flow margin
2.3%19.2%
0.3%118th of 145 · median 10.0%
HIMS and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthFYGross marginttmNet marginttmROEttmFCF marginttmDebt / equitylatest
HIMS Hims & Hers Health, Inc.$2.9B +59.0%63.8%-6.7%-53.7%0.3%-
BKD Brookdale Senior Living Inc.$2.9B +2.2%27.6%-1.3%-0.5%-
RVTY Revvity$2.9B +3.7%-8.6%3.5%20.1%0.36
NTRA Natera, Inc.$2.9B +35.9%--5.7%-8.8%1.8%0.04
NVST Envista Holdings Corp$2.9B +8.3%55.9%22.0%20.5%8.4%0.46
MEDP Medpace Holdings, Inc.$2.8B +20.0%-18.2%88.5%23.5%-
All 162 companies in the group

Where each dollar goes

Revenue through the costs to the net profit, from the 10-K income statement and revenue by region

From $1.5B of sales to $126.0M of profit FY2024

  • Federal $1.4B
  • Foreign $26.8M
Revenue to Gross profit: $1.2BRevenue to Cost of revenue: $303.4MGross profit to Operating profit: $61.9MGross profit to Operating expenses: $1.1BOperating profit to Net profit: $61.9MOther income to Net profit: $64.1M Revenue: $1.5B REVENUE $1.5B +69% Y/Y Gross profit: $1.2B · 79% margin GROSS PROFIT $1.2B 79% margin · +64% Y/Y Cost of revenue: $303.4M · 21% of revenue COST OF REVENUE $303.4M 21% of revenue Operating profit: $61.9M · 4% margin OPERATING PROFIT $61.9M 4% margin Other income: $64.1M · 4% of revenue OTHER INCOME $64.1M 4% of revenue Operating expenses: $1.1B · 75% of revenue OPERATING EXPENSES $1.1B 75% of revenue Net profit: $126.0M · 9% margin NET PROFIT $126.0M 9% margin

From $2.3B of sales to $128.4M of profit FY2025

  • Federal $2.2B
  • Foreign $134.0M
Revenue to Gross profit: $1.7BRevenue to Cost of revenue: $614.3MGross profit to Operating profit: $105.6MGross profit to Operating expenses: $1.6BOperating profit to Net profit: $105.6MOther income to Net profit: $22.8M Revenue: $2.3B REVENUE $2.3B +59% Y/Y Gross profit: $1.7B · 74% margin GROSS PROFIT $1.7B 74% margin · +48% Y/Y Cost of revenue: $614.3M · 26% of revenue COST OF REVENUE $614.3M 26% of revenue Operating profit: $105.6M · 4% margin OPERATING PROFIT $105.6M 4% margin · +71% Y/Y Other income: $22.8M · 1% of revenue OTHER INCOME $22.8M 1% of revenue Operating expenses: $1.6B · 69% of revenue OPERATING EXPENSES $1.6B 69% of revenue Net profit: $128.4M · 5% margin NET PROFIT $128.4M 5% margin · +2% Y/Y

Where each $100 of sales went

FY2024
FY2025
  • Cost of revenue
  • Costs, tax, other
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement

Where the return on equity comes from

DuPont: net margin × asset turnover × leverage, FY2025 against FY2021 · 10-K XBRL, year-end balances

Return on equity 23.7% FY2021: -32.2% net income ÷ equity
Net margin 5.5% FY2021: -39.6% profit per $ of sales: 128.4M ÷ 2.3B
Asset turnover 1.09× FY2021: 0.65× sales per $ of assets: 2.3B ÷ 2.2B
Leverage 3.98× FY2021: 1.26× assets per $ of equity: 2.2B ÷ 540.9M

The three parts multiply to the return on equity. A higher return from leverage alone means more debt or less equity (buybacks shrink equity), not a better business. Year-end balances as filed, not averages, so each number is one line of one 10-K; hover a box for its XBRL tags.

Profitability

  • Net margin below the peer median
    -6.7% vs 6.8%
  • Gross margin up over 5 years
    73.6% → 73.8%
  • Return on equity below 15%
    -53.7%
  • A profit in 2 of 7 years
Net margin, FY2019 to FY2025: -87.3% to 5.5%

Cash and shareholders

  • Free cash flow positive in 3 of 4 years
    $57.4M last year
  • Share count up over 5 years
    +46.1%
  • Cash from operations above net income
    $300.0M vs $128.4M
Free cash flow, FY2019 to FY2025: -33.7M to 57.4M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

Contracted revenue and deferred revenue

Backlog (remaining performance obligations) and cash received in advance, by balance sheet date · XBRL

Contract liabilities, current part

Paid in advance $144.1M cash received before delivery, not yet recognized as revenue, Sep 30, 2026 · +21.6% on a year earlier

Both are balance-sheet-date values from the 10-K and 10-Qs. Backlog is what is under contract, not a forecast: contracts can be cancelled or change in size, and a company counts them in its own way. Hover a number for its XBRL line; click it to open the filing.

Income statement, balance sheet and cash flow

Statements · XBRL, each 10-K and 10-Q

From EDGAR

HIMS's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year, the last 7. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Revenue2.3B
FY2019: 82.6MFY2020: 148.8MFY2021: 271.9MFY2022: 526.9MFY2023: 872.0MFY2024: 1.5BFY2025: 2.3B FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income128.4M
FY2019: -72.1MFY2020: -18.1MFY2021: -107.7MFY2022: -65.7MFY2023: -23.5MFY2024: 126.0MFY2025: 128.4M FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Free cash flow57.4M
FY2019: -FY2020: -FY2021: -FY2022: -33.7MFY2023: 47.0MFY2024: 198.3MFY2025: 57.4M FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Free cash flow after stock pay-77.8M
FY2019: -FY2020: -FY2021: -FY2022: -76.5MFY2023: -19.1MFY2024: 106.0MFY2025: -77.8M FY2019FY2020FY2021FY2022FY2023FY2024FY2025
EPS (diluted)0.51
FY2019: -2.07FY2020: -0.51FY2021: -0.58FY2022: -0.32FY2023: -0.11FY2024: 0.53FY2025: 0.51 FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Diluted shares258.2M
FY2019: 34.8MFY2020: 35.4MFY2021: 186.8MFY2022: 204.5MFY2023: 209.3MFY2024: 236.8MFY2025: 258.2M FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue by region

year to Dec 31, 2025
RevenueSharevs year before
Federal 2.2B94.3% +52.7%
Foreign 134.0M5.7% +399%

10-K 0001773751-26-000022, segment and revenue notes (XBRL).

Income statement

From EDGAR
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue82.6M148.8M271.9M526.9M872.0M1.5B2.3B
Cost of revenue38.0M39.3M67.4M118.2M157.1M303.4M614.3M
Gross profit44.6M109.5M204.5M408.7M714.9M1.2B1.7B
SG&A55.9M65.6M183.6M98.2M129.9M167.8M272.7M
Operating income-74.4M-15.1M-115.0M-68.7M-29.5M61.9M105.6M
Interest expense369K10K00---
Pretax income-72.0M-18.0M-110.8M-65.7M-21.6M71.7M123.9M
Income tax90K127K-3.1M-31K2.0M-54.3M-4.4M
Net income-72.1M-18.1M-107.7M-65.7M-23.5M126.0M128.4M
EPS (diluted)-2.07-0.51-0.58-0.32-0.110.530.51
Diluted shares34.8M35.4M186.8M204.5M209.3M236.8M258.2M
Depreciation & amortization260K1.1M4.1M7.5M9.5M17.1M54.5M
EBITDA-74.2M-14.1M-111.0M-61.2M-19.9M79.0M160.1M
Gross margin54.0%73.6%75.2%77.6%82.0%79.5%73.8%
Operating margin-90.1%-10.2%-42.3%-13.0%-3.4%4.2%4.5%
Net margin-87.3%-12.2%-39.6%-12.5%-2.7%8.5%5.5%
Revenue growth-+80.2%+82.8%+93.8%+65.5%+69.3%+59.0%
EPS growth-------3.8%

Cash flow

From EDGAR
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-74.9M-2.5M-34.4M-26.5M73.5M251.1M300.0M
Capital spending---7.2M26.5M52.8M242.6M
Free cash flow----33.7M47.0M198.3M57.4M
Stock-based pay (added back)8.0M5.8M67.2M42.8M66.1M92.3M135.2M
Free cash flow after stock pay----76.5M-19.1M106.0M-77.8M
Buybacks00002.0M83.0M90.0M
Acquisitions0046.5M0015.4M145.2M
Debt raised2.1M00-00970.0M
Debt repaid9.1M1.5M00---
Investing cash flow-39.3M-39.7M-156.3M34.7M-12.1M-19.0M-1.0B
Financing cash flow95.3M47.7M235.0M-33.1M-11.5M-107.8M729.6M

Stock-based pay and leases

From EDGAR
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)8.0M5.8M67.2M42.8M66.1M92.3M135.2M
Stock-based pay / revenue9.7%3.9%24.7%8.1%7.6%6.3%5.8%
Operating lease cost--1.8M1.9M2.4M3.0M13.5M
Operating lease cash paid--1.5M1.6M1.9M2.4M1.9M
Right-of-use assets-05.1M4.9M9.6M10.9M137.0M
Operating lease liabilities-05.5M5.3M9.9M11.3M148.0M

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Sources

Every figure is from the company's XBRL filed with each 10-K and 10-Q (data.sec.gov). Hover a number for its line item; click it to open the filing.

Also

Company numbers: the figures the company reports beyond the statements. Peers: ten years, side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HIMS/export.csv") into a cell.

Next:Peers in numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.